Boyer David W. bought NBIX
January 31, 2026 · Form 4 insider transaction
Boyer David W. bought 2,096 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,096
Price
$0.00
Total value
N/A
InsiderBoyer David W.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after5,902
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes an aggregate of 241 shares purchased on February 28, 2025 and August 29, 2025 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.